Levels of phosphorylated S6 (p-S6), a marker of mTOR/S6K activity, were statistically significantly lower in both the cardiac muscle and the liver in R2 group, received rapamycin every week, than in control HF group. This evidence concerns the gene RPS6KB1 and hydrops fetalis.